ns 1619 has been researched along with papaverine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bari, F; Busija, DW; Domoki, F; Veltkamp, R | 1 |
| Armstead, WM; Ben-Haim, G | 1 |
2 other study(ies) available for ns 1619 and papaverine
| Article | Year |
|---|---|
Potassium channel activators protect the N-methyl-D-aspartate-induced cerebral vascular dilation after combined hypoxia and ischemia in piglets.
Topics: Analysis of Variance; Animals; Animals, Newborn; Benzimidazoles; Calcitonin Gene-Related Peptide; Female; Hypoxia, Brain; Ischemic Attack, Transient; Kainic Acid; Male; N-Methylaspartate; Papaverine; Picolines; Potassium Channels; Pyrans; Swine; Vasodilator Agents | 1998 |
Stimulus duration-dependent contribution of k(ca) channel activation and cAMP to hypoxic cerebrovasodilation.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Benzimidazoles; Blood Gas Analysis; Blood Pressure; Cerebral Arteries; Cerebrovascular Circulation; Cyclic AMP; Enzyme Inhibitors; Female; Hypoxia, Brain; Male; Neuropeptides; Papaverine; Peptides; Physical Stimulation; Pia Mater; Pituitary Adenylate Cyclase-Activating Polypeptide; Potassium Channel Blockers; Potassium Channels; Swine; Thionucleotides; Time Factors; Vasodilation; Vasodilator Agents | 2000 |